March 13, 2023 Posted by: GMI-Co Category: Uncategorized No Comments The drugmaker would pay $229 a share in cash for the biotech company and its pioneering cancer treatments. Leave a Reply Cancel reply post a comment app.gmi-co.com Looking for growth capital? Contact GMI Capital for Financing Impact, Bridging Gaps, Building Wealth Contact Us